Qulipta (Atogepant) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in adults. It works by blocking the receptor where CGRP usually binds, which can help reduce the frequency of migraine attacks.

Common side effects of Qulipta include
- Fatigue
- Show Full Answer

Qulipta (Atogepant) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in adults. It works by blocking the receptor where CGRP usually binds, which can help reduce the frequency of migraine attacks.

Common side effects of Qulipta include:
- Fatigue
- Dizziness
- Constipation
- Nausea

For more details about this treatment, you can visit the provided link: [Qulipta (Atogepant) for Migraine | MyMigraineTeam](https://www.MyMigraineTeam.com/treatments/qulipta).

 This AI-generated response comes from MyMigraineTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Qulipta (Atogepant) for Migraine | MyMigraineTeam

Zolmig (Zolmitriptan) for Migraine | MyMigraineTeam